» Articles » PMID: 31090945

How Many Recovery Attempts Does It Take to Successfully Resolve an Alcohol or Drug Problem? Estimates and Correlates From a National Study of Recovering U.S. Adults

Overview
Specialty Psychiatry
Date 2019 May 16
PMID 31090945
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alcohol and other drug (AOD) problems are commonly depicted as chronically relapsing, implying multiple recovery attempts are needed prior to remission. Yet, although a robust literature exists on quit attempts in the tobacco field, little is known regarding patterns of cessation attempts related to alcohol, opioid, stimulant, or cannabis problems. Greater knowledge of such estimates and the factors associated with needing fewer or greater attempts may have utility for health policy and clinical communication efforts and approaches.

Methods: Cross-sectional, nationally representative survey of U.S. adults (N = 39,809) who reported resolving a significant AOD problem (n = 2,002) and assessed on number of prior serious recovery attempts, demographic variables, primary substance, clinical histories, and indices of psychological distress and well-being.

Results: The statistical distribution of serious recovery attempts was highly skewed with a mean of 5.35 (SD = 13.41) and median of 2 (interquartile range [IQR] = 1 to 4). Black race, prior use of treatment and mutual-help groups, and history of psychiatric comorbidity were associated with higher number of attempts, and more attempts were associated independently with greater current distress. Number of recovery attempts did not differ by primary substance (e.g., opioids vs. alcohol).

Conclusions: Estimates of recovery attempts differed substantially depending on whether the mean (5.35 recovery attempts) or median (2 recovery attempts) was used as the estimator. Implications of this are that the average may be substantially lower than anticipated because cultural expectations are often based on AOD problems being "chronically relapsing" disorders implicating seemingly endless tries. Depending on which one of these estimates is reported in policy documents or communicated in public health announcements or clinical settings, each may elicit varying degrees of help-seeking, hope, motivation, and the use of more assertive clinical approaches. The more fitting, median estimate of attempts should be used in clinical and policy communications given the distribution.

Citing Articles

A within-person investigation of recovery identity following substance use disorder: examining the impact of recovery-focused social contexts.

Lancaster J, Apsley H, Brick T, Cleveland H Front Public Health. 2025; 13:1534432.

PMID: 40013040 PMC: 11861067. DOI: 10.3389/fpubh.2025.1534432.


Remission from addiction: erasing the wrong circuits or making new ones?.

Engeln M, Ahmed S Nat Rev Neurosci. 2024; 26(2):115-130.

PMID: 39663409 DOI: 10.1038/s41583-024-00886-y.


Evaluating a 30-day alcohol abstinence challenge in heavy-drinking individuals with and without chronic pain: Feasibility, safety, and perceived benefits.

You D, Ziadni M, Vest N, Megerdichian N, Maronesy T, Castro R Alcohol. 2024; 122:91-100.

PMID: 39489405 PMC: 11757067. DOI: 10.1016/j.alcohol.2024.10.046.


The use of online methods to recruit and follow a hard-to-reach population in the Peer Alternatives for Addiction Study 2021 Cohort.

Zemore S, Delk J, Mericle A, Martinez P, Timko C Alcohol Clin Exp Res (Hoboken). 2024; 48(9):1795-1806.

PMID: 39107089 PMC: 11576241. DOI: 10.1111/acer.15413.


Is peer support a tipping point for the opioid use disorder crisis in Appalachia? Research holds the answer.

Horn K, Mathis S, Nagle L, Hagaman A, Dunkenberger M, Pack R Harm Reduct J. 2024; 21(1):122.

PMID: 38914988 PMC: 11197219. DOI: 10.1186/s12954-024-01041-7.


References
1.
McLellan A, Lewis D, OBrien C, KLEBER H . Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000; 284(13):1689-95. DOI: 10.1001/jama.284.13.1689. View

2.
Koob G, Le Moal M . Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2000; 24(2):97-129. DOI: 10.1016/S0893-133X(00)00195-0. View

3.
Charney D, Nemeroff C, Lewis L, Laden S, Gorman J, Laska E . National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry. 2002; 59(3):262-70. DOI: 10.1001/archpsyc.59.3.262. View

4.
Kessler R, Barker P, Colpe L, Epstein J, Gfroerer J, Hiripi E . Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003; 60(2):184-9. DOI: 10.1001/archpsyc.60.2.184. View

5.
Hubbard R, Craddock S, Anderson J . Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003; 25(3):125-34. DOI: 10.1016/s0740-5472(03)00130-2. View